Thomas Welte

610 total citations
19 papers, 393 citations indexed

About

Thomas Welte is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Thomas Welte has authored 19 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Nephrology and 4 papers in Immunology. Recurrent topics in Thomas Welte's work include Renal Diseases and Glomerulopathies (3 papers), Bacterial Genetics and Biotechnology (3 papers) and Protein Structure and Dynamics (2 papers). Thomas Welte is often cited by papers focused on Renal Diseases and Glomerulopathies (3 papers), Bacterial Genetics and Biotechnology (3 papers) and Protein Structure and Dynamics (2 papers). Thomas Welte collaborates with scholars based in Germany, Switzerland and Australia. Thomas Welte's co-authors include Hans‐Georg Koch, Friedel Drepper, Bettina Warscheid, Renuka Kudva, Ilie Sachelaru, Narcis-Adrian Petriman, Bettina L. Knapp, Lukas Sturm, David Braig and Matthias Müller and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and Molecular Cell.

In The Last Decade

Thomas Welte

19 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Welte Germany 11 228 136 68 61 53 19 393
Vanessa Bruat Canada 8 175 0.8× 106 0.8× 41 0.6× 15 0.2× 13 0.2× 9 354
Vivek Bhatia United States 8 173 0.8× 38 0.3× 27 0.4× 7 0.1× 17 0.3× 8 500
Daniel Fox Australia 3 368 1.6× 14 0.1× 138 2.0× 78 1.3× 13 0.2× 7 428
Dolores Martín Spain 9 189 0.8× 28 0.2× 34 0.5× 48 0.8× 8 0.2× 14 507
Xiaoxia Zuo China 8 205 0.9× 37 0.3× 89 1.3× 12 0.2× 10 0.2× 26 384
Andrea Schmidt Germany 12 343 1.5× 252 1.9× 46 0.7× 2 0.0× 27 0.5× 22 591
Rongfeng Wu China 12 129 0.6× 65 0.5× 140 2.1× 26 0.4× 9 0.2× 24 431
Taiga Yamazaki Japan 14 376 1.6× 126 0.9× 46 0.7× 10 0.2× 7 0.1× 24 594
Ke Qiao China 14 227 1.0× 53 0.4× 73 1.1× 3 0.0× 8 0.2× 29 539
Anita Imm United States 10 343 1.5× 174 1.3× 20 0.3× 372 6.1× 11 0.2× 14 658

Countries citing papers authored by Thomas Welte

Since Specialization
Citations

This map shows the geographic impact of Thomas Welte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Welte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Welte more than expected).

Fields of papers citing papers by Thomas Welte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Welte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Welte. The network helps show where Thomas Welte may publish in the future.

Co-authorship network of co-authors of Thomas Welte

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Welte. A scholar is included among the top collaborators of Thomas Welte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Welte. Thomas Welte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Welte, Thomas, et al.. (2023). HbA1c‐dependent projection of long‐term renal outcomes. Journal of Internal Medicine. 295(2). 206–215. 11 indexed citations
2.
Ganner, Athina, Simon Lagies, Lu Wang, et al.. (2023). SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC. Cells. 12(6). 835–835. 4 indexed citations
3.
Welte, Thomas, Markus A. Schramm, Xavier Bemtgen, et al.. (2023). Identification of Covariates Modulating B‐Cell Repopulation Kinetics in Subjects Receiving Rituximab Treatment. Arthritis & Rheumatology. 75(11). 2045–2053. 5 indexed citations
4.
Welte, Thomas, et al.. (2023). Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study. BMC Nephrology. 24(1). 8–8. 13 indexed citations
5.
Hug, Martin J., et al.. (2023). Clinical covariates influencing clinical outcomes in primary membranous nephropathy. BMC Nephrology. 24(1). 235–235. 1 indexed citations
6.
Ábrahám, Hajnalka, Thomas Welte, Xavier Bemtgen, et al.. (2023). Atrial fibrillation and survival on a medical intensive care unit. International Journal of Cardiology. 399. 131673–131673. 2 indexed citations
7.
Welte, Thomas, Michael Stadler, Daniel Heß, et al.. (2023). Convergence of multiple RNA-silencing pathways on GW182/TNRC6. Molecular Cell. 83(14). 2478–2492.e8. 10 indexed citations
8.
Huzly, Daniela, et al.. (2022). Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune disease. BMC Infectious Diseases. 22(1). 734–734. 2 indexed citations
9.
Petriman, Narcis-Adrian, Friedel Drepper, Ilie Sachelaru, et al.. (2019). Noncompetitive binding of PpiD and YidC to the SecYEG translocon expands the global view on the SecYEG interactome in Escherichia coli. Journal of Biological Chemistry. 294(50). 19167–19183. 30 indexed citations
10.
Welte, Thomas, Alex Tuck, Panagiotis Papasaikas, et al.. (2019). The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1. Genes & Development. 33(17-18). 1221–1235. 30 indexed citations
11.
Welte, Thomas, Maximilian Seidl, Karsten Häffner, et al.. (2018). Treating C3 glomerulopathy with eculizumab. BMC Nephrology. 19(1). 7–7. 41 indexed citations
12.
Welte, Thomas, Kristin Technau‐Hafsi, Elke Neumann‐Haefelin, et al.. (2016). Successful Management of Calciphylaxis in a Kidney Transplant Patient. Transplantation Direct. 2(4). e70–e70. 8 indexed citations
13.
Sachelaru, Ilie, Narcis-Adrian Petriman, Renuka Kudva, et al.. (2013). YidC Occupies the Lateral Gate of the SecYEG Translocon and Is Sequentially Displaced by a Nascent Membrane Protein. Journal of Biological Chemistry. 288(23). 16295–16307. 82 indexed citations
14.
Welte, Thomas, Renuka Kudva, Lukas Sturm, et al.. (2011). Promiscuous targeting of polytopic membrane proteins to SecYEG or YidC by theEscherichia colisignal recognition particle. Molecular Biology of the Cell. 23(3). 464–479. 69 indexed citations
16.
Trewhella, Jill, Thomas Welte, Timothy J. Ryan, et al.. (2009). Domain Organization of the Monomeric Form of the Tom70 Mitochondrial Import Receptor. Journal of Molecular Biology. 388(5). 1043–1058. 32 indexed citations
17.
Reinhart, Konrad, Frank M. Brunkhorst, Hans-Georg Bone, et al.. (2006). [Diagnosis and therapy of sepsis: guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].. PubMed. 55 Suppl 1. 43–56. 18 indexed citations
18.
Hoopmann, Michael R., et al.. (2003). Arzneimittelverordnungen bei koronarer Herzkrankheit: Werden die Therapieempfehlungen beachtet?. Zeitschrift für Kardiologie. 92(6). 466–475. 6 indexed citations
19.
Welte, Thomas, Michael Bohnert, & Stefan Pollak. (2003). Prevalence of rhabdomyolysis in drug deaths. Forensic Science International. 139(1). 21–25. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026